Skip to main content

Table 1 Clinical data

From: Extent of cortical involvement in amyotrophic lateral sclerosis – an analysis based on cortical thickness

Pat.

Age

Sex

Dur.

RUE (75)

LUE (75)

RLE (45)

LLE (45)

Bulbar (0–14)

Babinski (0–2)

Spasticity (0–32)

Reflexes (0–13)

ALSFRS-R

ALSFRS-R PR/M6

ALSFRS-R PR/M(t)

1

59

m

30

68

69

41

41

2

0

0

0

43

0.5

0.2

2

59

m

13

75

64

31

27

0

0

0

0

37

1.8

0.8

3

31

m

17

64

62

45

45

0

2

0

12

42

1.2

0.4

4

68

m

22

75

73

45

42

2

2

4

4

40

0.7

0.4

5

65

m

25

72

75

26

16

0

1

0

6

37

0.7

0.4

6

53

m

38

74

75

26

23

0

0

0

0

43

0.2

0.1

7

34

w

18

70

71

45

45

4

2

0

12

39

1.0

0.5

8

62

m

18

63

73

45

45

4

0

0

12

40

0.7

0.4

9

49

m

19

54

55

45

45

0

2

0

0

41

0.3

0.4

10

60

m

30

58

57

45

45

2

2

0

5

33

1.5

0.5

11

77

m

34

70

71

22

37

0

2

2

12

33

1.7

0.4

12

63

w

12

75

75

45

45

3

0

0

11

45

0.2

0.3

13

66

m

23

61

71

44

44

0

1

0

0

48

0.0

0.0

14

72

m

25

69

71

40

41

3

2

4

6

48

1.0

0.3

  1. Pat. = patient; Dur. = duration in months; m = man, w = woman; RUE, LUE, RLE, LLE: right upper, left upper, right lower, left lower extremity; ALSFRS-R: ALS functional rating scale- revised, PR/M6 progression rate for the 6 months prior to MR-scanning, PR/M(t) progression rate per month for the entire duration of the disease.